Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life

Author:

Graff Lesley A12,Fowler Sharyle3,Jones Jennifer L4,Benchimol Eric I5678ORCID,Bitton Alain9,Huang James Guoxian5,Kuenzig M Ellen56ORCID,Kaplan Gilaad G1011ORCID,Lee Kate12,Mukhtar Mariam S13,Tandon Parul14ORCID,Targownik Laura E14,Windsor Joseph W10ORCID,Bernstein Charles N215ORCID

Affiliation:

1. Department of Clinical Health Psychology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada

2. University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada

3. Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

4. Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada

5. SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada

6. Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada

7. ICES, Toronto, Ontario, Canada

8. Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada

9. Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada

10. Department of Medicine, University of Calgary, Calgary, Alberta, Canada

11. Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada

12. Crohn’s and Colitis Canada, Toronto, Ontario, Canada

13. Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia

14. Division of Gastroenterology and Hepatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada

15. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada

Abstract

Abstract There has been a dramatic rise in mental health difficulties during the coronavirus disease 2019 (COVID-19) pandemic. While young adults have the lowest risk of hospitalization and mortality due to COVID-19, they have been identified as being at highest risk of detrimental mental health outcomes during the pandemic, along with women, those with lower socioeconomic status and those with pre-existing mental health conditions. Somewhat of a crisis in mental health has emerged across the general population through the evolution of the pandemic. A national Canadian survey identified a quadrupling of those experiencing pervasive elevated anxiety symptoms early in the pandemic compared to pre-pandemic levels, and a doubling of those with pervasive elevated depressive symptoms. Independent of the pandemic, persons with inflammatory bowel disease (IBD) can face multiple challenges related to their disease, which can result in a significant psychosocial burden and psychologic distress. Anxiety and depression have been found to be more prevalent in persons with IBD. Many potential factors contribute to the increased psychologic distress and negative impacts on mental health of the COVID-19 pandemic on persons with IBD. These include the fears of contracting COVID-19 or infecting other people. Many believe that IBD or its treatments predispose them to an increased risk of COVID-19 or a worse outcome if acquired. Concerns about access to health care add to mental distress. People with IBD generally report lower quality of life (QOL) compared to community controls. Psychologic interventions, in addition to adequate disease control, have been shown to improve health-related QOL. Uncertainty is another factor associated with reduced health-related QOL. Most studies suggest that persons with IBD have suffered QOL impairment during the pandemic in comparison to the pre-pandemic period. Uncertainties brought on by the pandemic are important contributors for some of the reduction in QOL.

Funder

Crohn's and Colitis Canada

Canadian Institutes of Health Research

Pfizer

AbbVie Corporation

Takeda Canada Inc.

Publisher

Oxford University Press (OUP)

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3